
- Applied Clinical Trials-01-01-2007
- Volume 0
- Issue 0
eShowcase: QUMAS Compliance Closed-Loop Process
System treats compliance as a single, repeatable process to ensure organizational quality
System treats compliance as a single, repeatable process to ensure organizational quality
QUMAS (Florham Park, NJ) has released an end-to-end closed-loop compliance solution for life science companies. The QUMAS Compliance Closed-Loop Process™, which the company says is the first product of its kind in the industry, automates the tracking and management of compliance, business, and quality issues enterprise-wide.
The solution integrates various tasks with other processes critical to regulatory compliance. Rather than treating compliance as a series of silos that vary with department and/or product lifecycle stage, the Compliance Closed-Loop Process treats it as a single procedure.
The QUMAS approach automates the generation of internal or external complaints, product nonconformances, deviations, audits, investigations, and all other compliance actions. The tool captures, records, routes, and verifies completion and approvals while auditing each step in a sponsor's quality management process.
QUMAS, (800) 577-1545,
Articles in this issue
about 19 years ago
eShowcase: TCN e-Systemsabout 19 years ago
Clinical Research Faces Scrutiny in Year Aheadabout 19 years ago
Beyond Blockbustersabout 19 years ago
Roadmap to Implementing the EU Directiveabout 19 years ago
Meet the EAB: Aaron F. Bartloneabout 19 years ago
New Year Brings New Opportunitiesabout 19 years ago
ACT European Summit Reportabout 19 years ago
Stopping a Trial Early for Treatment Benefit: Pros & Consabout 19 years ago
Reverse Auctions: Crusade or Curse?about 19 years ago
eShowcase: CogState DataPointNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.




